Skip to main content

Table 1 Sustained virologic response (SVR) by age, gender and fibrosis stage (N = 1525), nationwide HCV elimination program, Georgia, April 28, 2015–September 30, 2016

From: High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia

 

Total n (%)

N = 1525

SVR achieved n (%)

N = 1374

Unadjusted OR and 95% CI

Adjusted OR and 95% CI

Age group

 18–30

7

7 (100.00)

 

 31–45

411

393 (95.62)

1

 

 46–60

986

862 (87.42)

0.32 (0.19, 0.53)

 

 > 60

121

112 (92.56)

0.57 (0.25, 1.30)

 

Gender

 Male

1450

1300 (89.66)

1

 

 Female

75

74 (98.67)

8.54 (1.18, 61.87)

 

Fibrosis stage

 F4

892

764 (85.65)

1

1

 F3 or F3/F4

633

610 (96.37)

4.44 (2.82, 7.01)

4.18 (2.64, 6.61)

Treatment regimen

 SOF/RBV

566

449 (79.33)

1

1

 SOF/INF/RBV

959

925 (96.45)

7.09 (4.76, 10.56)

6.72 (4.49, 10.06)